WHO ICTRP trial
Comparison of intermediate and high dose valaciclovir for the prophylaxis of CMV…
ISRCTN78766104 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN78766104 |
|---|---|
| Public title | Comparison of intermediate and high dose valaciclovir for the prophylaxis of CMV viraemia in allogeneic stem cell transplant recipients |
| Scientific title | Comparison of intermediate and high dose valaciclovir for the prophylaxis of CMV viraemia in allogeneic stem cell transplant recipients |
| Primary sponsor | Department of Health (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | United Kingdom |
| Conditions | Infections and Infestations: Cytomegalovirus (CMV) infection Infections and Infestations Cytomegalovirus disease |
| Interventions | Randomised controlled trial. |
| Registration date | Dec 9, 2003 |
| Target size | 110 |
| Secondary IDs | N0256114044 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: